Table 1. Transplant characteristicsa

* ESRD, end-stage renal disease; HLA, human leukocyte antigen.
Recipients
    race
        white77.8%
        non-white22.2%
    gender
        male58.7%
    age
        mean (SD)40.2 (12.3)
        range(18 to 75)
Donors
    race
        white78.0%
        non-white22.0%
    gender
        male34.3%
    age
        mean (SD)41.8 (10.9)
        range(18 to 70)
Cause of ESRD
    diabetes mellitus23.1%
    hypertension8.3%
    glomerulonephritis38.6%
    interstitial7.9%
    polycystic7.4%
    other14.7%
Chronic dialysis
    preemptive25.6%
    peritoneal dialysis21.2%
    hemodialysis53.2%
Level of HLA matches
    09.0%
    111.9%
    27.5%
    342.3%
    48.5%
    51.6%
    619.3%
Relationship to donor
    sibling49.2%
    parent18.2%
    offspring9.7%
    other related2.1%
    spouse14.6%
    other unrelated6.2%
Use of induction therapy12.6%
Type of calcineurin inhibitor at discharge from transplantation
    none4.9%
    cyclosporine61.8%
    tacrolimus33.3%